All articles tagged with #psychedelic medicine
A comprehensive review of a decade's research highlights ayahuasca's potential in treating PTSD and anxiety disorders by influencing emotional processing and memory through serotonin receptors. The study, led by researchers at the University of São Paulo, underscores the need for more clinical trials to explore ayahuasca's therapeutic applications and safety considerations.
An FDA advisory committee has recommended against approving MDMA-assisted therapy for PTSD, citing insufficient evidence of its effectiveness and concerns over potential abuse and clinical trial misconduct. Despite promising results from Lykos Therapeutics' trials, the committee highlighted gaps in research data and the unregulated nature of the accompanying psychotherapy. The FDA will consider these recommendations in its final decision, which could significantly impact the future of psychedelic medicine.
MDMA-assisted therapy for post-traumatic stress disorder (PTSD) could receive federal approval in 2024, and Colorado has already passed a law allowing its use. A recent study sponsored by the Multidisciplinary Association for Psychedelic Studies found that MDMA, also known as ecstasy or molly, combined with talk therapy can reduce PTSD symptoms. The study's results are expected to be submitted for FDA approval later this year. If approved, Colorado's existing law would allow the use of MDMA in the state. Colorado has been at the forefront of drug decriminalization, having previously legalized cannabis and decriminalized psilocybin mushrooms.